Association Between Inpatient Medication Treatment for Opioid Use Disorder and Reduced One-Year All-Cause Mortality...

Area of Science:

• Infectious Diseases
• Addiction Medicine
• Public Health

Background:

• Invasive bacterial infections (IBIs) frequently lead to hospitalization among individuals with opioid use disorder (OUD).
• Mortality rates remain a concern for patients with OUD experiencing severe infections.
• Understanding factors influencing outcomes in this population is critical.

Purpose of the Study:

• To investigate the association between inpatient medication for opioid use disorder (MOUD) administration and one-year all-cause mortality.
• To evaluate the impact of MOUD on survival in patients hospitalized with IBIs.

Main Methods:

• Retrospective cohort study design.
• Inclusion of patients hospitalized with diagnosed invasive bacterial infections.
• Analysis of MOUD administration during inpatient stay.
• Assessment of one-year all-cause mortality as the primary outcome.

Main Results:

• Patients receiving MOUD during hospitalization showed a statistically significant reduction in one-year all-cause mortality compared to those who did not.
• This association persisted after adjusting for potential confounders.
• Further subgroup analyses explored specific IBIs and MOUD types.

Conclusions:

• Inpatient MOUD administration is associated with improved survival outcomes in patients hospitalized with invasive bacterial infections.
• Initiating or continuing MOUD during acute care settings may be a vital strategy to reduce mortality in this vulnerable population.
• Further research should focus on optimal MOUD protocols in the context of severe infections.